Merendino Lauren - Insider Non-Derivative Transactions at Day One Biopharmaceuticals, Inc. (DAWN) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 17, 2025, Merendino Lauren's relationship to Day One Biopharmaceuticals, Inc. (DAWN) is Officer (Chief Commercial Officer), and currently has 50,809 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other DAWN insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Merendino Lauren - Insider Non-Derivative Transactions of DAWN Common Stock

Merendino Lauren - Insider Non-Derivative Transactions at DAWN

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 18, 2025	Sell -- (Common Stock)	3726	8.91	50809
Nov 16, 2025	M -- (Common Stock)	3162	0	47161
Nov 16, 2025	M -- (Common Stock)	3687	0	50848
Nov 16, 2025	M -- (Common Stock)	3687	0	54535
Aug 19, 2025	Sell -- (Common Stock)	3766	6.77	41931
Aug 16, 2025	M -- (Common Stock)	3162	0	38323
Aug 16, 2025	M -- (Common Stock)	3687	0	42010
Aug 16, 2025	M -- (Common Stock)	3687	0	45697
May 17, 2025	Sell -- (Common Stock)	3927	6.26	35161
May 16, 2025	M -- (Common Stock)	3162	0	31714
May 16, 2025	M -- (Common Stock)	3687	0	35401
May 16, 2025	M -- (Common Stock)	3687	0	39088